U.S. Compression Therapy Market | USD 2.33 Billion by 2034
The U.S. compression therapy market size was exhibited at USD 1.75 billion in 2024 and is projected to hit around USD 2.33 billion by 2034, growing at a CAGR of 2.91% during the forecast period 2024 to 2034.
| Report Coverage | Details |
| Market Size in 2025 | USD 1.80 Billion |
| Market Size by 2034 | USD 2.33 Billion |
| Growth Rate From 2024 to 2034 | CAGR of 2.91% |
| Base Year | 2024 |
| Forecast Period | 2024-2034 |
| Segments Covered | Technology, End use, Distribution Channel |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Key Companies Profiled | Cardinal Health; 3M; SIGVARIS GROUP; Essity ; Julius Zorn, Inc.; HARTMANN USA, Inc; Bauerfeind USA Inc.; medi USA; BIOCOMPRESSION SYSTEMS; Gottfried Medical, Inc. |
Growing awareness about venous disorders such as chronic venous insufficiency (CVI) and deep vein thrombosis (DVT) is driving demand for compression therapy products. Educational campaigns and health initiatives are highlighting the benefits of compression therapy in managing these conditions. The increasing prevalence of chronic conditions such as diabetes, obesity, and hypertension are contributing to a higher incidence of venous and lymphatic disorders, which in turn drives the demand for compression therapy. According to the CDC, 38.4 million people of all ages, or 11.6% of the U.S. population, had diabetes.
The rise in the number of orthopedic procedures is another factor causing an increased demand for compression therapy as a component of postoperative care and rehabilitation protocols. The major factors causing a rise in these procedures are attributed to increased geriatric population, sport-related injuries, and advancements in surgical techniques giving rise to orthopedic surgeries, such as joint replacements (knee or hip replacements), fracture repairs, ligament reconstruction and arthroscopic surgeries. For instance, the American College of Rheumatology updated February 2024, recorded about 790,000 knee replacement surgeries and 544,000 hip replacement procedures being conducted annually, and the number continues to increase owing to the rise in geriatric population.
As the world's population ages, there is a subsequent increase in the demand for healthcare services and infrastructure to address the unique & evolving healthcare needs of older adults. The U.S. has a rapidly growing elderly population, which is associated with increased healthcare spending. According to America's Health Rankings 2022 data, approximately 58 million adults aged 65 and above currently reside in the U.S., constituting around 17.3% of the nation's population. Projections indicate that by 2040, this proportion is anticipated to grow to 22%. This demographic is more prone to circulatory issues, varicose veins, and edema, all of which are treated with compression therapy. As a result, the demand for compression products is rising, fueled by healthcare spending on geriatric care.
Healthcare spending in the U.S. is directed toward managing chronic conditions such as venous disorders, diabetes, and lymphedema, which are prevalent among the aging population. According to CMS data, by July 2024, U.S. healthcare spending grew by 4.1% in 2022, reaching USD 4.5 trillion or USD 13,493 per person. Compression therapy is a standard treatment for these conditions, leading to increased demand for compression garments, stockings, and bandages. With rising healthcare costs, there is a growing emphasis on preventive care to manage chronic conditions early. Compression therapy is recommended as a preventive measure for conditions like deep vein thrombosis (DVT), driving market growth.
Based on technology, the static technology segment dominated the market within 2024. The segment has witnessed considerable growth due to the high convenience and user-friendly qualities of this technology. The sizable share acquired by this segment can be attributed to the increased accessibility of these products in treating edema and sports-related injuries to enable pain & pressure relief. Furthermore, patients and physicians are inclined toward static technology due to its advantages, accounting for its dominant share.
Furthermore, the introduction of new products in the static compression therapy segment has significantly boosted the market. Static compression therapy, which includes products like compression stockings, bandages, and garments, is essential for managing various medical conditions such as chronic venous insufficiency, lymphedema, and post-surgical recovery.
For instance, in October 2024, Medi GmbH & Co. launched the Medi Rehab one compression stocking, which is available in thigh stocking and calf stocking versions with either an open or closed toe. Particularly in the conservative or postoperative treatment of ankle joint injuries or Achilles tendon ruptures, the calf stocking with an open toe makes it particularly easy and comfortable to put on and take off.
Dynamic compression therapy technology is emerging as one of the fastest-growing segments in the market. This technology offers enhanced therapeutic benefits for various conditions. Dynamic compression therapy is known for its ability to improve blood flow, reduce edema, and accelerate the healing process, particularly for conditions such as deep vein thrombosis (DVT), lymphedema, and chronic venous insufficiency. The ability to provide more effective treatment compared to static compression is driving its adoption in clinical and home settings.
The hospital End Use segment dominated the market in 2024 with a share of 31.05%. Compression therapy is integrated into hospital protocols for managing conditions such as venous disorders, wound care, and post-surgical recovery. The use of compression garments, bandages, and devices is often mandated as part of treatment guidelines, ensuring consistent demand within hospitals. In many hospitals, compression stockings or pneumatic compression devices are automatically prescribed for bedridden or limited mobility patients to prevent DVT, making these products a staple in hospital care.
The home healthcare segment is anticipated to grow significantly over the forecast period. Innovations in compression therapy devices designed specifically for home use, such as portable pneumatic compression pumps and easy-to-use compression garments, are driving growth in this segment. These products are designed to be user-friendly and require minimal assistance. Patients increasingly prefer receiving care in the comfort of their own homes rather than in clinical settings. Home-based compression therapy allows for greater convenience and personal comfort, leading to higher patient satisfaction and adherence.
The institutional sales segment dominated the market share 55.0% in 2024. Due to their high patient volume, institutions such as hospitals and large clinics procure compression therapy products in bulk, which drives significant sales through institutional channels. Compression therapy is integrated into standard treatment protocols for various conditions, including venous disorders, lymphedema, and post-surgical recovery.
This integration ensures that these products are regularly used and purchased through institutional channels. Institutions have the resources to invest in advanced compression therapy technologies, such as high-end pneumatic compression devices and specialized compression garments. These technologies are more complex and expensive, making them more commonly purchased through institutional channels.
The retail sales distribution channel is anticipated to grow at the fastest CAGR in the market. There is a rising awareness among consumers about the benefits of compression therapy for managing conditions such as varicose veins, chronic venous insufficiency, and lymphedema. This heightened awareness drives increased consumer interest and demand for compression products available through retail channels. The growth of e-commerce has made it easier for consumers to access compression therapy products from the comfort of their homes.
Online retailers offer a wide range of compression products, including stockings, sleeves, and bandages, with convenient delivery options. Retail channels, including pharmacies, medical supply stores, and specialty retailers, have expanded their product offerings to include compression therapy items. This increased availability makes it easier for consumers to purchase these products without needing a prescription or visiting a healthcare facility.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the U.S. compression therapy market
By Technology
By End Use
By Distribution Channel
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers